HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Pholedrine: a substitute for hydroxyamphetamine as a diagnostic eyedrop test in Horner's syndrome.

Abstract
Mydriatic responses to eyedrops containing the indirect acting sympathomimetic amines tyramine, hydroxyamphetamine, and pholedrine have been compared in 10 healthy subjects. Pholedrine, the n-methyl derivative of hydroxyamphetamine, at a concentration of 1% had effects similar to those produced by 0.5% hydroxyamphetamine itself. Pretreatment with topical guanethidine attenuated its responses and in 13 patients with unilateral Horner's syndrome it distinguished clearly those five patients who had preganglionic from the eight with postganglionic lesions. It is concluded that 1% pholedrine may be substituted for 0.5% hydroxyamphetamine, which is no longer available, as a diagnostic agent for use in Horner's syndrome.
AuthorsA T Bates, S Chamberlain, M Champion, L Foley, E Hughes, B Jani, H Mehta, S E Smith
JournalJournal of neurology, neurosurgery, and psychiatry (J Neurol Neurosurg Psychiatry) Vol. 58 Issue 2 Pg. 215-7 (Feb 1995) ISSN: 0022-3050 [Print] England
PMID7876854 (Publication Type: Comparative Study, Journal Article)
Chemical References
  • Ophthalmic Solutions
  • Sympathomimetics
  • Methamphetamine
  • pholedrine
  • p-Hydroxyamphetamine
  • Tyramine
  • Guanethidine
Topics
  • Adolescent
  • Adult
  • Aged
  • Female
  • Guanethidine
  • Horner Syndrome (diagnosis)
  • Humans
  • Male
  • Methamphetamine (analogs & derivatives)
  • Middle Aged
  • Ophthalmic Solutions
  • Pupil (drug effects)
  • Sympathomimetics
  • Tyramine
  • p-Hydroxyamphetamine

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: